Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
WVE · NASDAQ · Pharmaceutical Preparations
$2.56−0.16 (−5.88%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Wave Life Sciences (WVE) · oqro.io/stocks/WVE · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Duquesne Family Office disclosed a new position in WVE for Q3 2026Source5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Maverick Capital, Ltd. cut its WVE stake below 5% (0%)SourceInsider trade · Traded Aug 22, 2025 · Filed Aug 27, 2025
CEO sold ~$2.19M of WVE shares in the open marketSourceInsider trade · Traded Aug 22, 2025 · Filed Aug 27, 2025
Director sold ~$100K of WVE shares in the open marketSourceInsider trade · Traded Aug 15, 2025 · Filed Aug 20, 2025
Director sold ~$194K of WVE shares in the open marketSourceInsider trade · Traded Aug 13, 2025 · Filed Aug 14, 2025
Director sold ~$85K of WVE shares in the open marketSourceInsider trade · Traded Aug 5, 2025 · Filed Aug 8, 2025
Director sold ~$43K of WVE shares in the open marketSourceInsider trade · Traded Aug 5, 2025 · Filed Aug 8, 2025
Director sold ~$9.9K of WVE shares in the open marketSourceInsider trade · Traded Jun 13, 2025 · Filed Jun 14, 2025
Director sold ~$209K of WVE shares in the open marketSourceInsider trade · Traded Mar 20, 2025 · Filed Mar 22, 2025
Director sold ~$103K of WVE shares in the open marketSourceInsider trade · Traded Mar 7, 2025 · Filed Mar 8, 2025
CEO sold ~$1.62M of WVE shares in the open marketSourceInsider trade · Traded Nov 25, 2024 · Filed Nov 28, 2024
CEO sold ~$750K of WVE shares in the open marketSourceInsider trade · Traded Nov 15, 2024 · Filed Nov 16, 2024
CEO sold ~$734K of WVE shares in the open marketSourceInsider trade · Traded Nov 8, 2024 · Filed Nov 14, 2024
Officer sold ~$576K of WVE shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 19, 2024
CEO sold ~$1.36M of WVE shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 19, 2024
Officer sold ~$1.12M of WVE shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 19, 2024
Officer sold ~$902K of WVE shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 19, 2024
Officer sold ~$533K of WVE shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 19, 2024
Officer sold ~$304K of WVE shares in the open marketSourceInsider trade · Traded Sep 27, 2024 · Filed Oct 1, 2024
10% owner purchased ~$22.3M of WVE shares in the open marketSource